Authors

• Kirstie H. T. W. Wong (ORCID: https://orcid.org/0000-0003-4374-490X)
• Zhihan Jiang (ORCID: https://orcid.org/0000-0003-4857-7143)
• Janice Ching Nam Leung
• Dawn Hei Lum (ORCID: https://orcid.org/0000-0002-4602-306X)
• Patrick Ip (ORCID: https://orcid.org/0000-0002-6797-6898)
• Rosa Sze Man Wong (ORCID: https://orcid.org/0000-0003-4745-1899)
• Adrienne Y L Chan (ORCID: https://orcid.org/0000-0002-3011-8320)
• David Coghill (ORCID: https://orcid.org/0000-0003-3017-9737)
• Edith C.‐H. Ngai (ORCID: https://orcid.org/0000-0002-3454-8731)
• Ian Chi Kei Wong (ORCID: https://orcid.org/0000-0001-8242-0014)

Institutions

• Department of Health (CN)
• The University of Melbourne (AU)
• Aston University (GB)
• University of Groningen (NL)
• Chinese University of Hong Kong (HK)
• Duchess of Kent Children's Hospital (CN)
• University College London (GB)
• University of Hong Kong (HK)

Publication Details

Journal

JAACAP Open

Published

2024-11-24

DOI

https://doi.org/10.1016/j.jaacop.2024.11.003

Citations

5

Primary Topic

Attention Deficit Hyperactivity Disorder

Type

article

Field-Weighted Citation Impact

1.93

Funders

• Amgen
• Bristol-Myers Squibb
• Pfizer
• World Health Organization
• University of Cambridge
• University College London
• University of Oxford
• European Commission
• Rijksuniversiteit Groningen
• University of Hong Kong
• Aston University
• Servier
• Hong Kong Government
• Medical Research Council
• National Health and Medical Research Council
• Health and Medical Research Fund
• School of Pharmacy, University College London